← Back to the catalogue
Amino acids
Leucine
Branched-chain amino acid studied in nutritional, protein and energy metabolism; it is the main activator of the mTOR pathway and of muscle protein synthesis.
Application contexts
- Performance and muscle function
- Cardiometabolic health
Matrices
- Faeces
- Breast milk
- Tissues · muscle and liver
- Serum or plasma
- Urine
Related techniques
- ¹H-NMR
Related publications
- Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease. 2023 · Cardiovascular diabetology · 19 citations
- Metabolomics Approach to Identify Biomarkers of Acute and Subacute Mastitis in Milk Samples: A Pilot Case-Control Study. 2024 · Metabolites · 4 citations
- Assessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition. 2026 · PloS one · 1 citation
Related news
- NMR Metabolomics in Animal Models: A Key Tool for Translational Research 10 April 2025 · Panel: NMR low-molecular-weight metabolites
- Metabolomics in Sports: Applications in Performance and Recovery 24 October 2024 · Panel: NMR low-molecular-weight metabolites
- Role of Metabolomics in Infectious Diseases: A Cross-sectional Approach 19 September 2024 · Panel: NMR low-molecular-weight metabolites
Show 7 more Show less
- Desvelando Misterios de la Complejidad Lipoproteica en Diabetes Tipo 2 y Riesgo Cardiovascular 29 April 2024 · in Spanish · Panel: NMR low-molecular-weight metabolites
- Biosfer Teslab at the forefront of NMR sample analysis 26 March 2024 · Panel: NMR low-molecular-weight metabolites
- Exploring Metabolomics through Nuclear Magnetic Resonance and its Impact on Nutritional Interventions 13 February 2024 · Panel: NMR low-molecular-weight metabolites
- The Importance of Branched-Chain Amino Acids (BCAAs) in Metabolism Monitoring 08 February 2024 · Panel: NMR low-molecular-weight metabolites
- MetBalance test: Monitor your metabolic health and revolutionize the way you take care of yourself 29 January 2024 · Panel: NMR low-molecular-weight metabolites
- What is metabolomics and how is it applied in diabetes? 13 November 2023 · Panel: NMR low-molecular-weight metabolites
- Liposcale for early and reliable diagnosis and prognosis of breast cancer patients 08 September 2021 · Panel: NMR low-molecular-weight metabolites
Related projects
- TB-OMICS 2025 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
- DALÍ 2024 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
- AVANTE 2023 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
Show 8 more Show less
- HARMONi 2023 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
- COST Action AtheroNET 2022 · Consortium partner · Panel: NMR low-molecular-weight metabolites
- CARDIOSCOPE 2022 · Consortium partner · Panel: NMR low-molecular-weight metabolites
- Companion diagnostic for Saroglitazar 2021 · Beneficiary company · Panel: NMR low-molecular-weight metabolites
- Torres Quevedo · Colorectal cancer 2021 · Beneficiary company · Panel: NMR low-molecular-weight metabolites
- VISIONING 2021 · Co-principal investigator, with the IRB CatSud metabolomics platform · Panel: NMR low-molecular-weight metabolites
- Torres Quevedo · Diagnostic metabolomics 2020 · Beneficiary company · Panel: NMR low-molecular-weight metabolites
- Cardiometabolic prediction 2018 · Beneficiary company · Panel: NMR low-molecular-weight metabolites